Alison Merrick

1.4k total citations
17 papers, 805 citations indexed

About

Alison Merrick is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Alison Merrick has authored 17 papers receiving a total of 805 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Immunology, 6 papers in Oncology and 4 papers in Molecular Biology. Recurrent topics in Alison Merrick's work include Immunotherapy and Immune Responses (10 papers), Cancer Immunotherapy and Biomarkers (5 papers) and Immune Cell Function and Interaction (4 papers). Alison Merrick is often cited by papers focused on Immunotherapy and Immune Responses (10 papers), Cancer Immunotherapy and Biomarkers (5 papers) and Immune Cell Function and Interaction (4 papers). Alison Merrick collaborates with scholars based in United Kingdom, United States and Ireland. Alison Merrick's co-authors include Alan Melcher, Peter J. Selby, Richard G. Vile, Fiona Errington‐Mais, Kevin J. Harrington, Paul Hatfield, Elizabeth J. Ilett, Cheryl M. McCormick, Dana L. Helmreich and Hardev Pandha and has published in prestigious journals such as The Journal of Immunology, Clinical Cancer Research and British Journal of Cancer.

In The Last Decade

Alison Merrick

17 papers receiving 778 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alison Merrick United Kingdom 14 320 320 223 182 95 17 805
Wojciech Dawicki Canada 22 260 0.8× 1.1k 3.5× 73 0.3× 271 1.5× 35 0.4× 36 1.6k
Zongming Chen United States 12 149 0.5× 266 0.8× 46 0.2× 114 0.6× 90 0.9× 22 859
Martin P. Keough United States 10 81 0.3× 112 0.3× 146 0.7× 326 1.8× 96 1.0× 11 747
Kerry B. Gunning United States 6 90 0.3× 69 0.2× 213 1.0× 420 2.3× 17 0.2× 7 652
Christopher Parrish United Kingdom 12 364 1.1× 187 0.6× 199 0.9× 316 1.7× 41 0.4× 42 698
Lloyd H. Graf United States 13 104 0.3× 142 0.4× 183 0.8× 296 1.6× 67 0.7× 18 628
Tatsuo Yudate Japan 11 50 0.2× 315 1.0× 80 0.4× 276 1.5× 149 1.6× 28 910
Claudia Mongini Argentina 13 84 0.3× 241 0.8× 59 0.3× 613 3.4× 60 0.6× 32 975
W. Jay Ramsey United States 16 587 1.8× 228 0.7× 1.2k 5.6× 1.3k 7.1× 160 1.7× 34 1.8k
Tsuyoshi Uchide Japan 17 138 0.4× 61 0.2× 72 0.3× 241 1.3× 49 0.5× 78 813

Countries citing papers authored by Alison Merrick

Since Specialization
Citations

This map shows the geographic impact of Alison Merrick's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alison Merrick with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alison Merrick more than expected).

Fields of papers citing papers by Alison Merrick

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alison Merrick. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alison Merrick. The network helps show where Alison Merrick may publish in the future.

Co-authorship network of co-authors of Alison Merrick

This figure shows the co-authorship network connecting the top 25 collaborators of Alison Merrick. A scholar is included among the top collaborators of Alison Merrick based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alison Merrick. Alison Merrick is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Merrick, Alison, Elizabeth J. Ilett, & Alan Melcher. (2009). JX-594, a targeted oncolytic poxvirus for the treatment of cancer.. PubMed. 10(12). 1372–82. 33 indexed citations
2.
Prestwich, Robin, Karen J. Scott, Julia Brown, et al.. (2009). The feasibility of establishing a programme of adjuvant autologous vaccination for renal cell carcinoma. British Journal of Urology. 103(6). 740–746. 2 indexed citations
3.
Errington‐Mais, Fiona, Lynette P. Steele, Alison Merrick, et al.. (2008). OK432-Activated Human Dendritic Cells Kill Tumor Cells via CD40/CD40 Ligand Interactions. The Journal of Immunology. 181(5). 3108–3115. 26 indexed citations
4.
White, Charles L., Katie Twigger, Laura Vidal, et al.. (2008). Characterization of the adaptive and innate immune response to intravenous oncolytic reovirus (Dearing type 3) during a phase I clinical trial. Gene Therapy. 15(12). 911–920. 124 indexed citations
5.
Hatfield, Paul, Alison Merrick, Emma J. West, et al.. (2008). Optimization of Dendritic Cell Loading With Tumor Cell Lysates for Cancer Immunotherapy. Journal of Immunotherapy. 31(7). 620–632. 80 indexed citations
6.
Prestwich, Robin, Fiona Errington‐Mais, Paul Hatfield, et al.. (2007). The Immune System — is it Relevant to Cancer Development, Progression and Treatment?. Clinical Oncology. 20(2). 101–112. 83 indexed citations
7.
Georgopoulos, Nikolaos T., et al.. (2007). CD40‐mediated death and cytokine secretion in colorectal cancer: A potential target for inflammatory tumour cell killing. International Journal of Cancer. 121(6). 1373–1381. 32 indexed citations
9.
10.
Errington‐Mais, Fiona, Andrew Bateman, Tim Kottke, et al.. (2006). Allogeneic tumor cells expressing fusogenic membrane glycoproteins as a platform for clinical cancer immunotherapy.. Clinical Cancer Research. 12(4). 1333–1341. 24 indexed citations
11.
Merrick, Alison, et al.. (2006). Social instability alters HPA responses to repeated stress during adolescence in male and female rats. Frontiers in Neuroendocrinology. 27(1). 52–52. 2 indexed citations
12.
Errington‐Mais, Fiona, Alison Merrick, Andrew Bateman, et al.. (2005). Fusogenic membrane glycoprotein-mediated tumour cell fusion activates human dendritic cells for enhanced IL-12 production and T-cell priming. Gene Therapy. 13(2). 138–149. 43 indexed citations
13.
Merrick, Alison, Fiona Errington‐Mais, Kate Milward, et al.. (2005). Immunosuppressive effects of radiation on human dendritic cells: reduced IL-12 production on activation and impairment of naïve T-cell priming. British Journal of Cancer. 92(8). 1450–1458. 107 indexed citations
14.
Hatfield, Paul, Alison Merrick, Kevin J. Harrington, et al.. (2004). Radiation-induced cell death and dendritic cells: potential for cancer immunotherapy?. Clinical Oncology. 17(1). 1–11. 31 indexed citations
15.
Merrick, Alison, et al.. (2003). FGFR3IIIS: a novel soluble FGFR3 spliced variant that modulates growth is frequently expressed in tumour cells. British Journal of Cancer. 89(7). 1276–1284. 20 indexed citations
16.
Randall, Valerie A., Nigel A. Hibberts, M. Julie Thornton, et al.. (2001). Do androgens influence hair growth by altering the paracrine factors secreted by dermal papilla cells?. PubMed. 11(4). 315–20. 39 indexed citations
17.
Randall, Valerie A., Nigel A. Hibberts, M. Julie Thornton, et al.. (2000). The Hair Follicle: A Paradoxical Androgen Target Organ. Hormone Research in Paediatrics. 54(5-6). 243–250. 68 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026